2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)hex-5-enoic acid

Catalog No. :
ACDHYI175
CAS No. :
193223-97-1
Molecular Formula :
C21H21NO4
Molecular Weight :
351.40

IUPAC Name:2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)hex-5-enoic acid

2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)hex-5-enoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$156.00Login to see priceIn stockInquiry
250mg97%$311.00Login to see priceIn stockInquiry
1g97%$925.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)hex-5-enoic acid
IUPAC Name2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)hex-5-enoic acid
MDL No.MFCD30187726
Molecular FormulaC21H21NO4
Molecular Weight351.40
SMILESC=CCCC(NC(OCC1C2=C(C3=C1C=CC=C3)C=CC=C2)=O)C(O)=O
InChI KeyCPJQXKHZCVDRSX-UHFFFAOYSA-N
SynonymFmoc-DL-Abu(vinyl)-OH;5-Hexenoic acid, 2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-;2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)hex-5-enoic acid;Fmoc-DL- Homoallylglycine;2-(Fmoc-amino)-5-hexenoic acid
CAS No.193223-97-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACDHYI175 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDHYI175 route product structure diagram
    ACDHYI175193223-97-1 In Stock
Inquiry

2. ACDHYI175 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSEUW805 route compound structure diagram
    ACSEUW80516258-05-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDHYI175 route product structure diagram
    ACDHYI175193223-97-1 In Stock
Inquiry

Comments (0)